Speaker

Dr Shunan Qi is a radiation oncologist and Deputy Director of the Proton Therapy Center at the Langfang Campus of the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. She graduated from Peking Union Medical College and was a visiting scholar at Memorial Sloan Kettering Cancer Center.

Dr Qi serves on the Steering Committee of the International Lymphoma Radiation Oncology Group (ILROG) and contributes to several national lymphoma guidelines in China. Her clinical and research work focuses on precision radiotherapy and multidisciplinary treatment for lymphoma, particularly extranodal NK/T-cell lymphoma (ENKTCL). Using large-scale real-world datasets, she has contributed to disease modelling, risk stratification, and the development of risk-adapted treatment strategies for ENKTCL. She led the development of the ILROG international radiotherapy guidelines for ENKTCL as first author and a principal writing expert.

Her current research includes prospective clinical trials and accompanying translational studies evaluating the integration of radiotherapy with immunotherapy and chemotherapy. Her other areas of interest include modern radiotherapy for indolent lymphomas, treatment of relapsed or refractory aggressive lymphomas, and precision radiotherapy for abdominal malignancies.

姓名：亓姝楠

职务/职称：廊坊院区质子放疗中心副主任、放射治疗科医师

单位：中国医学科学院肿瘤医院

亓姝楠医生现任中国医学科学院肿瘤医院廊坊院区质子放疗中心副主任。毕业于北京协和医学院，曾赴美国纪念斯隆-凯特琳癌症中心访学。现任国际淋巴瘤放射肿瘤学协作组（ILROG）指导委员会委员，并参与多项中国淋巴瘤诊疗指南的制定。

长期从事淋巴瘤精准放疗和多学科综合治疗研究，重点聚焦结外NK/T细胞淋巴瘤（ENKTCL）。依托中国大样本真实世界诊疗数据，开展疾病模型构建和风险识别，推动ENKTCL风险分层及个体化治疗策略的优化。作为第一作者和主要执笔专家，组织并参与制定了ILROG结外NK/T细胞淋巴瘤国际放疗指南。

目前主要开展放疗联合免疫治疗或化疗的前瞻性临床研究及伴随转化研究。其他专业方向包括惰性淋巴瘤的现代精准放疗、复发或难治性侵袭性淋巴瘤的综合治疗，以及腹部肿瘤的精准放射治疗。